Načítá se...

Clinical development of nintedanib for advanced non-small-cell lung cancer

Angiogenesis is an essential process in the development, growth, and metastasis of malignant tumors including lung cancer. Several angiogenesis inhibitors have been developed as potential therapies for non-small-cell lung cancer (NSCLC). Nintedanib is a small-molecule tyrosine kinase inhibitor that...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Ther Clin Risk Manag
Hlavní autoři: Takeda, Masayuki, Okamoto, Isamu, Nakagawa, Kazuhiko
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove Medical Press 2015
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4654540/
https://ncbi.nlm.nih.gov/pubmed/26622180
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S76646
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!